DIAGNOSTICS AND THERAPY OF THE CORONARY HEART DISEASE (CHD)
Cardiovascular diseases top the list of the death causes for many years and are far ahead cancer, which rates the second reason of death. Among all variety of the cardiovascular disorders the garland of victory belongs to high blood pressure (hypertension) and coronary heart disease (CHD), which is also known as angina or breast pang.
The CHD is the disorder of the blood supply of the heart muscle (myocardium, cardiac muscle). The heart is supplied by blood through the so-called coronary arteries, the branches of which penetrate the heart muscles and distribute oxygen and nutrients in all heart areas.
The CHD patients develop luminal stenosis (narrowing) of the coronary arteries. This narrowing is induced by atherosclerosis plaques, blood clots and arteries spasms and combination of these factors. Chronic CHD (partial gradual narrowing of coronary arteries) can be accompanied by the pains in the heart area, or can be painless, or disguised by the abdominal pains or some other atypical symptoms. Most frequently, acute ischemia or myocarditis (complete or almost complete block of coronary arteries) manifests as myocardial infarction, necrosis of the myocardial site, which is supplied by the blood of the damaged artery.
The past quarter of the last century celebrates the advances of endovascular cardiac surgery. The surgeons now are able to combat the consequences of CHD introducing special tubes into the vessels that are known as stents to extend the narrowed artery and restore the disordered blood supply. However, these surgeries are done either in acute myocardial infarction or in the case of the pronounced narrowing of coronary artery in the immediate threat of a heart attack. Such manipulations cannot be considered the therapy of CHD as these surgeries only combat the consequences of the log-term processes.
They do not influence the CHD mechanisms, do not prevent the formation of the atherosclerotic plaques or narrowing of other (not stented) coronary arteries and do not improve the microcirculation in the heart muscle. This is the reason why a single surgical procedure is not enough, most of the patients have to receive it several times. Another problem is the thrombosis of the implanted stents so that they must be replaced and often in emergency. Moreover, there are lot of patients with the so-called X syndrome or microcirculatory CHD when smaller vessels are damaged but it is technically impossible to implant stents in them. The CHD is different in every case.
All this speaks about the necessity of the therapeutic approaches aimed at the therapy of mechanisms that underlay the CHD: prevent the CHD progress, reduce the size of atherosclerotic plaques, prevent their and blood clots development, improve blood supply of heart muscle and so on. And in the patients with the implanted stents, too.
The specialists of NeuroVita clinical hospital can help you understand the clinical symptoms, pass the appropriate laboratory and functional tests, offer contemporary individually tailored therapy that not only corrects the clinical symptoms but also prevents further damage of the coronary vessels and recovers adequate blood supply of heart muscles. It restores “health” of the heart, copes with clinical symptoms, avoids poor “cardiac” future, such as cardiac infarctions and surgical interventions. The patients that have already received the stents implantation as well as the patients with microcirculatory CHD can also have the therapy.
